MUC4 expression by immunohistochemistry is a specific marker for BCR-ABL1+ and BCR-ABL1-like B-lymphoblastic leukemia

Kaumeyer, B; Fidai, S; Sukhanova, M; Yap, KL; Segal, J; Raca, G; Stock, W; McNeer, J; Lager, AM; Gurbuxani, S

Gurbuxani, S (通讯作者),Univ Chicago Med, 5841 S Maryland Ave,Rm TW055,MC0008, Chicago, IL 60637 USA.

LEUKEMIA & LYMPHOMA, 2022; 63 (6): 1436

Abstract

BCR-ABL1-like B-acute lymphoblastic leukemia (B-ALL) is a genetically heterogeneous group of high-risk B-ALL that benefits from targeted tyrosine kina......

Full Text Link